Zagazig University Digital Repository
Home
Thesis & Publications
All Contents
Publications
Thesis
Graduation Projects
Research Area
Research Area Reports
Search by Research Area
Universities Thesis
ACADEMIC Links
ACADEMIC RESEARCH
Zagazig University Authors
Africa Research Statistics
Google Scholar
Research Gate
Researcher ID
CrossRef
Optimization of injectable PLGA in-situ forming implants of anti-psychotic risperidone via Box-Behnken Design
Faculty
Pharmacy
Year:
2020
Type of Publication:
ZU Hosted
Pages:
Authors:
Staff Zu Site
Abstract In Staff Site
Journal:
Journal of Drug Delivery Science and Technology Elsevier B.V.
Volume:
58
Keywords :
Optimization , injectable PLGA in-situ forming implants
Abstract:
The current study aims to develop in-situ forming implants (ISFI) of anti-psychotic risperidone to customize schizophrenia therapy. Non-adherence to treatment is the most prevalent unsuccessful clinical outcome in schizophrenic patients. Poly(lactic-co-glycolic acid) (PLGA) was utilized to prepare ISFI using various solvents having different drug solubilization capacity. 33 Box-Behnken Design (BBD) was used to study the effects of independent variables; lactide concentration (A), solvent type (B) and solvent/polymer ratio (S/P) (C) on burst release after 6h (Y1), cumulative release after 40 days (Y2) and injectability time (Y3). Statistical analysis was followed by optimization process to minimize burst release and injectability time with targeted cumulative release to 50% at 40 days. BBD results represented the critical impacts of increasing lactide and PLGA concentrations on reducing drug burst and percent release. Rapid ISFI solidification using DMSO supported the high dispersed drug encapsulation and sustained release. Triacetin demonstrated a lag time between formulation injection and solidification that negatively affected the studied responses. The optimized formulation manifested burst (8.1%), cumulative release (51.08%) and 18 s for injection by mixing PLGA (75:25) and DMSO (S/P = 2.851). Compared with injectable commercial microspheres, ISFI emphasized their potential to enhance compliance and eliminate costs issues of additional oral therapy.
Author Related Publications
Department Related Publications
Mahmoud Mokhtar AhmedIbrahiem, "Phase Study and Characterization of Certain Developed Multicomponent Colloidal Systems and their Potential Application As Carriers for An Antimicrobial Agent", لايوجد, 1900
More
Amr Selim Ahmed Ali Abu Lila, "Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome", J.Stage, 2013
More
Amr Selim Ahmed Ali Abu Lila, "Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?", Elsevier, 2012
More
Azza Ali Hassan Solyman, "Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system", Informa health, 2013
More
Amr Selim Ahmed Ali Abu Lila, "Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model", Elsevier, 2009
More
جامعة المنصورة
جامعة الاسكندرية
جامعة القاهرة
جامعة سوهاج
جامعة الفيوم
جامعة بنها
جامعة دمياط
جامعة بورسعيد
جامعة حلوان
جامعة السويس
شراقوة
جامعة المنيا
جامعة دمنهور
جامعة المنوفية
جامعة أسوان
جامعة جنوب الوادى
جامعة قناة السويس
جامعة عين شمس
جامعة أسيوط
جامعة كفر الشيخ
جامعة السادات
جامعة طنطا
جامعة بنى سويف